European Leukemia Trial Registry
Trial: QOL II

less detail
Public Title Quality of Life and Symptoms in Patients With Newly Diagnosed MDS
Scientific Title Prognostic Significance and Longitudinal Assessment of Patient-reported Quality of Life and Symptoms in High-risk Myelodysplastic Syndromes. A Large-scale International Study.
Short Title QOL II
Id KN/ELN LN_GIMEMA_2008_367
Trialgroup GIMEMA
Type of Trial NIS, prospective
Phase N/A
Disease Myelodysplastic Syndrome(MDS) Intermedia II and high risk
Stage of Disease .
Age keine Angabe
Status No longer recruiting
Start of Recruitment 01.11.2008
Recruiting Countries Italy
Leader Efficace, PhD, Fabio
Scientific Contact Efficace, PhD, Fabio (Affliliation)
Shortprotocol Shortprotocol
Sponsors Gruppo Italiano Malattie EMatologiche dell'Adulto (Main Sponsor)
Other Registers NCT00809575 (primary Register)
created 08.03.2010 Irene Gleske
changed 01.06.2015 Hanna Ebert
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | |